Considering the fact that INHA expression can also be found in 60 other tumor entities, including 15 entities with a fraction of strongly positive cancers, INHA immunohistochemistry should only be applied as a part of a panel for the distinction of tumor entities. The gene discussed is INHA; the disease is cancer.